Gastrointestinal events were the most common adverse events in the retatrutide Phase 2 obesity trial. The study also reported a dose-related increase in heart rate that peaked during follow-up and then declined.
Adverse-event findings in monitored trials
An adverse-event table reflects the study’s definitions and observation window. A controlled trial can identify recurring signals while leaving uncertainty about rare events or longer exposure.
How to interpret the evidence
Read the absolute event counts, percentages and discontinuation data. Use the paper rather than product pages as the source of safety observations.
This research summary focuses on a defined endpoint or safety observation. Its relevance depends on the study’s population and follow-up.